All News
Filter News
Found 808,606 articles
-
NeuroVive Presents Preclinical Findings Of NV556 In NASH Showing Confirmatory Anti-Fibrotic Effects
4/20/2017
-
Meet The Lawyer Who Wants To Expose Big Pharma's Drug Pricing Secrets
4/20/2017
-
NIH Study In The New England Journal of Medicine Shows Novartis Drug Eltrombopag As First-Line Therapy With Standard Treatment Improves Responses In Severe Aplastic Anemia
4/20/2017
-
Oral Presentation At EASL Highlights ContraVir’s Tenofovir Exalidex (TXL) Antiviral Activity In Hepatitis B (HBV) Patients
4/20/2017
-
RedHill Biopharma Announces Peer-Reviewed Publication Of The Positive YELIVA Phase I Study Results In Advanced Solid Tumors
4/20/2017
-
Pfizer The Latest To Get Subpoenaed In U.S. IV Saline Solution Probe
4/20/2017
-
Eyevensys Receives Approval From The UK Medicines And Healthcare Products Regulatory Agency To Advance its EyeCET Platform Into Clinical Development
4/20/2017
-
uniQure Announces It Will Not Seek Marketing Authorization Renewal For Glybera In Europe
4/20/2017
-
BioPharmX Completes Last Subject Visit In Its Phase IIb Trial Of BPX-01, Expects To Report Topline Results First Half Of May 2017
4/20/2017
-
Phase I/II Clinical Trial Of Agenus' Anti-PD-1 Antibody Begins
4/20/2017
-
Celsion Announces Presentation Of OVATION Study Findings At The Upcoming ASCO 2017 Annual Meeting
4/20/2017
-
Prima Biomed Receives Approval For Third Cohort Of Phase I Melanoma Trial
4/20/2017
-
Clearside Biomedical Announces Completion Of Patient Enrollment In Phase I/II Open Label Clinical Trial Of CLS-TA In Diabetic Macular Edema
4/20/2017
-
SIGA Completes Enrollment And Dosing In Final Cohort Of Phase I Study Of IV Formulation Of TPOXX® (Tecovirimat) To Treat Smallpox
4/20/2017
-
Mateon Therapeutics Announces Initiation Of Investigator-Sponsored Phase I Study Of CA4P In Combination With Everolimus In Neuroendocrine Tumors
4/20/2017
-
BTG plc Release: First European Patients Treated With Dc Bead Lumi Radiopaque Drug-Eluting Beads
4/20/2017
-
Targovax Initiates First Clinical Trial With TG02, The Second Product From Its RAS-Peptide Immunotherapy Platform
4/20/2017
-
GRAIL Initiates The STRIVE Study To Advance Development Of Blood Tests To Detect Cancer Early
4/20/2017
-
Inventiva Announces Presentation Of Preclinical Results On IVA337 In NASH At The International Liver Congress 2017 (EASL)
4/20/2017
-
NIH Study In The New England Journal of Medicine Shows Novartis AG Drug Eltrombopag As First-Line Therapy With Standard Treatment Improves Responses In Severe Aplastic Anemia
4/20/2017